Financials
- Market Capitalization 537.1 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry İlaç Üreticileri - Genel
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.12
Fiyat/satışlar oranı
1.75
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2130 | MAZE Maze Therapeutics, Inc. - Common Stock | 27.70 USD | +2.18% | +4.33% | +11.24% | -38.49% | 1.54 B USD | ||
| 2166 | RAPP Rapport Therapeutics, Inc. - Common Stock | 30.15 USD | -1.63% | -8.41% | -31.94% | +15.12% | 1.45 B USD | ||
| 3016 | EIKN Eikon Therapeutics, Inc. - Common Stock | 7.26 USD | -2.81% | -3.97% | -18.88% | -57.42% | 393.24 M USD | ||
| 3364 | QTTB Q32 Bio Inc. - Common Stock | 8.74 USD | +4.80% | +5.05% | -20.33% | +122.96% | 260.19 M USD |